During the past decade, Pinnacle Clinical Research conducted 57 clinical trials. In the 10-year time frame, 57 clinical trials started and 22 clinical trials were completed, i.e. on average, 38.6% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 22 clinical trials were completed. i.e. 78.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pinnacle Clinical Research" #1 sponsor was "CymaBay Therapeutics, Inc." with 5 trials, followed by "Gilead Sciences" with 5 trials sponsored, "Allergan" with 3 trials sponsored, "Axcella Health, Inc" with 3 trials sponsored and "Galectin Therapeutics Inc." with 3 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pinnacle Clinical Research" #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator, "Antaros Medical" with 1 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 1 trials as a collaborator and "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Pinnacle Clinical Research" are "Non-Alcoholic Fatty Liver Disease" (6 trials), "Nonalcoholic Steatohepatitis" (6 trials), "NASH - Nonalcoholic Steatohepatitis" (5 trials), "Hepatic Impairment" (4 trials) and "NAFLD" (4 trials). Many other conditions were trialed in "Pinnacle Clinical Research" in a lesser frequency.

Most popular intervention types in "Pinnacle Clinical Research" are "Drug" (52 trials), "Other" (7 trials), "Biological" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (34 trials), "SEL" (4 trials), "Relamorelin" (3 trials), "ALT-801" (2 trials) and "AXA1125" (2 trials). Other intervention names were less common.

The vast majority of trials in "Pinnacle Clinical Research" are 56 trials for "All" genders.

Currently, there are NaN active trials in "Pinnacle Clinical Research". undefined are not yet recruiting, 11 are recruiting, 11 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 25 completed trials in Pinnacle Clinical Research, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Pinnacle Clinical Research, 9 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".